Jose Carlos Flores-Gonzalez

Jose Carlos Flores-Gonzalez

Auto-generated profile, based on publicly available information

Jose Carlos Flores-Gonzalez

Affiliation: Department of Clinical Pediatrics, Hospital Universitario Puerta del Mar, Cádiz, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JFJose C. Flores-González
Jose C. Flores-González
JMJuan Mayordomo-Colunga
Juan Mayordomo-Colunga
IJIolanda Jordan
Iolanda Jordan
AMAlicia Miras-Veiga
Alicia Miras-Veiga
CMCristina Montero-Valladares
Cristina Montero-Valladares
CGConcha Goñi-Orayen
Concha Goñi-Orayen
Objective. To determine the epidemiology and therapeutic management of patients with severe acute bronchiolitis (AB) admitted to paediatric intensive care units (PICUs) in Spain.Design. Descriptive, prospective, multicentre study.Setting. Sixteen Spanish PICUs.Patients. Patients with severe AB who required admission to any of the participating PICUs over 1 year.Interventions. Both epidemiological variables and medical treatment received were recorded.Results. A total of 262 patients were recruited; 143 were male (54.6%), with median age of 1 month (0–23). Median stay in the PICU was 7 days (1–46). Sixty patients (23%) received no nebuliser treatment, while the rest received a combination of inhalation therapies. One-quarter of patients (24.8%) received corticosteroids and 56.5% antibiotic therapy. High-flow oxygen therapy was used in 14.3% and noninvasive ventilation (NIV) was used in 75.6%. Endotracheal intubation was required in 24.4% of patients. Younger age, antibiotic therapy, and invasive mechanical ventilation (IMV) were risk factors that significantly increased the stay in the PICU.Conclusions. Spanish PICUs continue to routinely use nebulised bronchodilator treatment and corticosteroid therapy. Despite NIV being widely used in this condition, intubation was required in one-quarter of cases. Younger age, antibiotic therapy, and IMV were associated with a longer stay in the PICU.

17 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JFJ. Carlos Flores-González
J. Carlos Flores-González
MMMiguel A. Matamala-Morillo
Miguel A. Matamala-Morillo
PRPatricia Rodríguez-Campoy
Patricia Rodríguez-Campoy
JPJuan J. Pérez-Guerrero
Juan J. Pérez-Guerrero
BSBelén Serrano-Moyano
Belén Serrano-Moyano
B(Bronchiolitis of Cadiz Study group (BronCaS)
Bronchiolitis of Cadiz Study group (BronCaS)
There is no evidence that the epinephrine-3% hypertonic saline combination is more effective than 3% hypertonic saline alone for treating infants hospitalized with acute bronchiolitis. We evaluated the efficacy of nebulized epinephrine in 3% hypertonic saline. We performed a randomized, double-blind, placebo-controlled clinical trial in 208 infants hospitalized with acute moderate bronchiolitis. Infants were randomly assigned to receive nebulized 3% hypertonic saline with either 3 mL of epinephrine or 3 mL of placebo, administered every four hours. The primary outcome measure was the length of hospital stay. A total of 185 infants were analyzed: 94 in the epinephrine plus 3% hypertonic saline group and 91 in the placebo plus 3% hypertonic saline group. Baseline demographic and clinical characteristics were similar in both groups. Length of hospital stay was significantly reduced in the epinephrine group as compared with the placebo group (3.94 ±1.88 days vs. 4.82 ±2.30 days, P = 0.011). Disease severity also decreased significantly earlier in the epinephrine group (P = 0.029 and P = 0.036 on days 3 and 5, respectively). In our setting, nebulized epinephrine in 3% hypertonic saline significantly shortens hospital stay in hospitalized infants with acute moderate bronchiolitis compared to 3% hypertonic saline alone, and improves the clinical scores of severity from the third day of treatment, but not before. EudraCT 2009-016042-57

30 September 2011 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
JFJ.C. Flores-González
J.C. Flores-González
AHA. Hernández-González
A. Hernández-González
CRC. Rodríguez-López
C. Rodríguez-López
VRV. Roldán-Cano
V. Roldán-Cano
FRF. Rubio-Quiñones
F. Rubio-Quiñones
SPS. Pantoja-Rosso
S. Pantoja-Rosso

5 January 2022 in Tomography
Verified
Journal Article
Open access
PDF file
MRMoises Rodriguez-Gonzalez
Moises Rodriguez-Gonzalez
RCRodriguez Campoy
Rodriguez Campoy
AEAna Estalella-Mendoza
Ana Estalella-Mendoza
ACAna Castellano-Martinez
Ana Castellano-Martinez
JFJose Carlos Flores-Gonzalez
Jose Carlos Flores-Gonzalez
We aimed to delineate cardiopulmonary interactions in acute bronchiolitis and to evaluate the capacity of a combined cardiopulmonary ultrasonography to predict the need for respiratory support. This was a prospective observational single-center study that includes infants <12 month of age admitted to a hospital due to acute bronchiolitis. All the included patients underwent clinical, laboratory and cardiopulmonary ultrasonographic evaluation at the same time point within 24 h of hospital admission. The existence of significant correlation between cardiac and respiratory parameters was the primary outcome. The association of different cardiopulmonary variables with the need of respiratory support higher than O2, the length of stay hospitalization, the PICU stay and the duration of respiratory support were a secondary outcome. We enrolled 112 infants (median age 1 (0.5–3) months; 62% males) hospitalized with acute bronchiolitis. Increased values of the pulmonary variables (BROSJOD score, pCO2 and LUS) showed moderate correlations with NT-proBNP and all echocardiographic parameters indicative of pulmonary hypertension and myocardial dysfunction (Tei index). Up to 36 (32%) infants required respiratory support during the hospitalization. This group presented with higher lung ultrasound score (p < 0.001) and increased values of NT-proBNP (p < 0.001), the Tei index (p < 0.001) and pulmonary artery pressures (p < 0.001). All the analyzed respiratory and cardiac variables showed moderate-to-strong correlations with the LOS of hospitalization and the time of respiratory support. Lung ultrasound and echocardiography showed a moderate-to-strong predictive accuracy for the need of respiratory support in the ROC analysis, with the AUC varying from 0.74 to 0.87. Those cases of bronchiolitis with a worse pulmonary status presented with a more impaired cardiac status. Cardiopulmonary ultrasonography could be a useful tool to easily identify high-risk populations for complicated acute bronchiolitis hospitalization.

27 May 2017 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
JFJ. Carlos Flores-González
J. Carlos Flores-González
AEAna Estalella-Mendoza
Ana Estalella-Mendoza
ASAlfonso María Lechuga Sancho
Alfonso María Lechuga Sancho
AHArturo Hernández-González
Arturo Hernández-González
FRFernando Rubio-Quiñones
Fernando Rubio-Quiñones
MSMónica Saldaña-Valderas
Mónica Saldaña-Valderas

27 November 2018 in Pediatric Drugs
Verified
Journal Article
Closed access
PDF file
JFJose Carlos Flores-González
Jose Carlos Flores-González
AEAna Estalella-Mendoza
Ana Estalella-Mendoza
PRPatricia Rodríguez-Campoy
Patricia Rodríguez-Campoy
MSMónica Saldaña-Valderas
Mónica Saldaña-Valderas
ASAlfonso María Lechuga Sancho
Alfonso María Lechuga Sancho